Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study by Vidal-Petiot, Emmanuelle, MD, Ford, Ian, Prof, Greenlaw, Nicola, MSc, Ferrari, Roberto, Prof, Fox, Kim M, Prof, Tardif, Jean-Claude, Prof, Tendera, Michal, Prof, Tavazzi, Luigi, Prof, Bhatt, Deepak L, Prof, Steg, Philippe Gabriel, Prof

Get full text

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial by Bousser, Marie-Germaine, Prof, Amarenco, Pierre, Prof, Chamorro, Angel, Prof, Fisher, Marc, Prof, Ford, Ian, MD, Fox, Kim M, Prof, Hennerici, Michael G, Prof, Mattle, Heinrich P, Prof, Rothwell, Peter M, Prof, de Cordoüe, Agnès, MD, Fratacci, Marie-Dominique, MD

Get full text

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURREN... by Mehta, Shamir R, Dr, Tanguay, Jean-Francois, MD, Eikelboom, John W, MD, Jolly, Sanjit S, MD, Joyner, Campbell D, Prof, Granger, Christopher B, MD, Faxon, David P, Prof, Rupprecht, Hans-Jurgen, MD, Budaj, Andrzej, Prof, Avezum, Alvaro, MD, Widimsky, Petr, Prof, Steg, Philippe Gabriel, Prof, Bassand, Jean-Pierre, Prof, Montalescot, Gilles, MD, Macaya, Carlos, MD, Di Pasquale, Giuseppe, MD, Niemela, Kari, MD, Ajani, Andrew E, MD, White, Harvey D, Prof, Chrolavicius, Susan, BA, Gao, Peggy, MSc, Fox, Keith AA, Prof, Yusuf, Salim, Prof

Get full text

Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study by Camidge, D Ross, Dr, Bang, Yung-Jue, Prof, Kwak, Eunice L, MD, Iafrate, A John, MD, Varella-Garcia, Marileila, Prof, Fox, Stephen B, Prof, Riely, Gregory J, MD, Solomon, Benjamin, MBBS, Ou, Sai-Hong I, MD, Kim, Dong-Wan, Prof, Salgia, Ravi, Prof, Fidias, Panagiotis, MD, Engelman, Jeffrey A, MD, Gandhi, Leena, MD, Jänne, Pasi A, MD, Costa, Daniel B, MD, Shapiro, Geoffrey I, MD, LoRusso, Patricia, DO, Ruffner, Katherine, MD, Stephenson, Patricia, ScD, Tang, Yiyun, PhD, Wilner, Keith, PhD, Clark, Jeffrey W, MD, Shaw, Alice T, MD

Get full text

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial by Coles, Alasdair J, Dr, Twyman, Cary L, MD, Arnold, Douglas L, Prof, Cohen, Jeffrey A, Prof, Confavreux, Christian, Prof, Fox, Edward J, MD, Hartung, Hans-Peter, Prof, Havrdova, Eva, Prof, Selmaj, Krzysztof W, Prof, Weiner, Howard L, Prof, Miller, Tamara, MD, Fisher, Elizabeth, PhD, Sandbrink, Rupert, MD, Lake, Stephen L, ScD, Margolin, David H, MD, Oyuela, Pedro, MD, Panzara, Michael A, MD, Compston, D Alastair S, Prof

Get full text

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlle... by Fox, Kim, Prof, Ford, Ian, Prof, Steg, P Gabriel, Prof, Tendera, Michal, Prof, Robertson, Michele, BSc, Ferrari, Roberto, Prof

Get full text